These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 222663)

  • 1. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR; Nowakowski KJ; Jackson IM
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
    Hermus AR; Pieters GF; Smals AG; Pesman GJ; Lamberts SW; Benraad TJ; van Haelst UJ; Kloppenborg PW
    N Engl J Med; 1988 Apr; 318(15):966-70. PubMed ID: 2832758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
    Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane].
    Kirkegaard C; Kolendorf K
    Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of Cushing's disease with paradoxical response to dexamethasone].
    Kubo M; Nakagawa K; Akikawa K; Matsubara M; Ishizuka T; Nakagawa S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):75-82. PubMed ID: 3009668
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous Graves' disease and Cushing's syndrome with unusually low levels of plasma cortisol.
    Kreines K; Esselborn VM
    J Clin Endocrinol Metab; 1968 Jun; 28(6):789-94. PubMed ID: 4297790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short and long-term administration of lisuride in Cushing's disease.
    Boscaro M; Merola G; Serafini E; Mantero F
    J Endocrinol Invest; 1985 Feb; 8(1):13-7. PubMed ID: 2985685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J; Valette A; Latrabe J; Codaccioni JL
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
    Richkind M
    Vet Med Small Anim Clin; 1981 Sep; 76(9):1301-4. PubMed ID: 6277079
    [No Abstract]   [Full Text] [Related]  

  • 18. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
    Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
    Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine for Cushing's disease.
    Kennedy AL; Montgomery DA
    Br Med J; 1977 Apr; 1(6068):1083-4. PubMed ID: 192411
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent progress in diagnosis of Cushing's disease].
    Teramoto A
    No Shinkei Geka; 1997 Jan; 25(1):7-15. PubMed ID: 8990462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.